Fidia Pharma USA, a subsidiary of Italian pharmaceutical manufacturer Fidia Farmaceutici, has introduced new packaging for its Hyalo Gyn vaginal hydration gel.
The packaging features an innovative feminine appearance in order to attract more customers.
Go deeper with GlobalData
Hyalo Gyn is a hormone-free, odourless gel specifically developed for women whose vaginal lining is not sufficiently hydrated.
Fidia Pharma USA president Aldo Donati said: “Many women often suffer silently from the bothersome symptoms associated with vaginal dryness, but they do not have to.
“Hyalo Gyn, with its unique hyaluronic acid derivative component Hydeal-D, was made for women to provide long-lasting hydration.
“Women trust that Hyalo Gyn can provide hydration in a non-hormonal vaginal hydrating gel without a messy buildup or unpleasant order.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"Keeping its same formulation, Hyalo Gyn now features new packaging that exudes a fresher, more feminine look that we believe is more attractive and better aligns with the comfort, hydration and relief that Hyalo Gyn provides to women.”
The company is involved in the hyaluronic acid market segment and aims to expand Fidia’s presence in the US and Canadian market.
Established in 1946, Fidia Farmaceutici markets acid-based products used in various applications in the biomedical field, including rheumatology, orthopaedics, surgery, wound care, tissue repair and dermo-aesthetics.
